MedPath

青神虹豪制药有限公司

Ownership
-
Established
2019-08-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Lanthanum Carbonate Chewable Tablets

Product Name
碳酸镧咀嚼片
Approval Number
国药准字H20213953
Approval Date
Dec 27, 2021
NMPA

Telmisartan and Amlodipine Tablets (Ⅱ)

Product Name
替米沙坦氨氯地平片(Ⅱ)
Approval Number
国药准字H20213466
Approval Date
Jun 8, 2021
NMPA

灵芝片

Approval Number
国药准字Z20053996
Approval Date
Sep 27, 2020
NMPA

银黄口服液

Approval Number
国药准字Z20053946
Approval Date
Aug 12, 2020
NMPA

灵芝胶囊

Approval Number
国药准字Z20053724
Approval Date
Aug 12, 2020
NMPA

香砂养胃软胶囊

Approval Number
国药准字Z20053748
Approval Date
Aug 12, 2020
NMPA

复方灵芝颗粒

Approval Number
国药准字Z20053747
Approval Date
Aug 12, 2020
NMPA

抗骨增生丸

Approval Number
国药准字Z20054577
Approval Date
Aug 12, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.